SlideShare a Scribd company logo
Key Messages we are communicating
The predominant symptoms of a C-IBS patient are abdominal pain,
bloating and constipation. These symptoms wax and wane and
affect all aspects of her life, leading to decreased quality of life.
Desired outcome:
 Bring to the doctor’s mind the disease area and the
patient group he sees and their symptoms
Key Messages: Disease related
 The impact of IBS is high as it is a prevalent condition
which takes up much of the doctors consultation time,
and the cost of IBS is measured in monetary terms as
well as an impact of the patients quality of life.
 Desired outcome:
Make IBS matter- it is not a non- disease it affects lives
Key Message: Disease /Patient related
 The impact of IBS on QOL versus other common
chronic episodic ondition is often worse than the other
conditions. It is therefore vital that the IBS patients are
treated, so that their QOL can be improved.
 Desired outcome:
 You have circumstances- to create a story ..
 Emphasize that IBS affects lives
Key Message: Patient related
 IBS has a serious impact on patient’s daily activities
and QOL.
 Desired outcome:
 Make it serious- bring to the treating physician the
urgency to treat patients
Key Message: Patient related
 C-IBS patients report a high incidence of abdominal
pain, bloating and constipation as their predominant
symptoms.
 Desired outcome:
 re-iterate to the doctor that the patient could use other
terms for describing that she is bloated or has
constipation. This again highlights the importance of
the doctor asking questions and discussing her
symptoms with her.
Key Message: Product Related
 Traditional therapies do not meet the need and only
treat individual symptoms. The traditional therapies
also exacerbate other symptoms and do not address
the underlying cause of C-IBS
Key Message: Product Related
 Zelmac is the only treatment that provides
multisymptom relief of C-IBS by working in 3 ways to
address the underlying cause
Key Message: Product Related
 Zelmac is the only treatment available that meets all 3
criteria and provides multisymptom relief of C-IBS.
Key Message: Product Related
 Zelmac provides rapid and sustained multisymptom
relief of the symptoms with C-IBS
Key Message: Product Related
 Zelmac provides rapid and sustained multisymptom
relief of the symptoms with C-IBS

More Related Content

Viewers also liked

Intro to apps with maps for series 40 russian
Intro to apps with maps for series 40 russianIntro to apps with maps for series 40 russian
Intro to apps with maps for series 40 russian
Microsoft Mobile Developer
 
Content Development Team: New Initiatives
Content Development Team: New InitiativesContent Development Team: New Initiatives
Content Development Team: New Initiatives
Informed Medical Decisions Foundation
 
Top Trans Survey Translation Issues
Top Trans Survey Translation IssuesTop Trans Survey Translation Issues
Top Trans Survey Translation Issues
Raya Wasser
 
Shared Decision Making Through the Decades
Shared Decision Making Through the DecadesShared Decision Making Through the Decades
Shared Decision Making Through the Decades
Informed Medical Decisions Foundation
 
Fact and Fiction - Mobile Oncologists - Digital Insights Group
Fact and Fiction - Mobile Oncologists - Digital Insights GroupFact and Fiction - Mobile Oncologists - Digital Insights Group
Fact and Fiction - Mobile Oncologists - Digital Insights Group
Digital Insights Group
 
Market research at the speed of light
Market research at the speed of lightMarket research at the speed of light
Market research at the speed of light
Len Starnes
 

Viewers also liked (6)

Intro to apps with maps for series 40 russian
Intro to apps with maps for series 40 russianIntro to apps with maps for series 40 russian
Intro to apps with maps for series 40 russian
 
Content Development Team: New Initiatives
Content Development Team: New InitiativesContent Development Team: New Initiatives
Content Development Team: New Initiatives
 
Top Trans Survey Translation Issues
Top Trans Survey Translation IssuesTop Trans Survey Translation Issues
Top Trans Survey Translation Issues
 
Shared Decision Making Through the Decades
Shared Decision Making Through the DecadesShared Decision Making Through the Decades
Shared Decision Making Through the Decades
 
Fact and Fiction - Mobile Oncologists - Digital Insights Group
Fact and Fiction - Mobile Oncologists - Digital Insights GroupFact and Fiction - Mobile Oncologists - Digital Insights Group
Fact and Fiction - Mobile Oncologists - Digital Insights Group
 
Market research at the speed of light
Market research at the speed of lightMarket research at the speed of light
Market research at the speed of light
 

Similar to Key messages post_launch

Key messages
Key messagesKey messages
Key messages
haithamo
 
A to b
A to bA to b
A to b
haithamo
 
Z a to_b_shift_slides
Z a to_b_shift_slidesZ a to_b_shift_slides
Z a to_b_shift_slides
haithamo
 
Git j club ibs difficult to treat21
Git j club ibs difficult to treat21Git j club ibs difficult to treat21
Git j club ibs difficult to treat21
Case records of Sulaymaniah General Teaching Hospital.
 
IBS(Irritable Bowel Syndrome) Management Update-2021
IBS(Irritable Bowel Syndrome) Management Update-2021IBS(Irritable Bowel Syndrome) Management Update-2021
IBS(Irritable Bowel Syndrome) Management Update-2021
Pritom Das
 
Irritable Bowel Syndrome with Constipation - Patient POV Slides - Dr. Lacy
Irritable Bowel Syndrome with Constipation - Patient POV Slides - Dr. LacyIrritable Bowel Syndrome with Constipation - Patient POV Slides - Dr. Lacy
Irritable Bowel Syndrome with Constipation - Patient POV Slides - Dr. Lacy
Devi Seal
 
Supporting guide
Supporting guideSupporting guide
Supporting guide
copdeducation
 
GIT irritable bowel syndrome (IBS) for 5th year 2011
GIT irritable bowel syndrome (IBS) for 5th year 2011GIT irritable bowel syndrome (IBS) for 5th year 2011
GIT irritable bowel syndrome (IBS) for 5th year 2011
Shaikhani.
 
Git j club ibs mistakes.
Git j club ibs mistakes.Git j club ibs mistakes.
Git j club ibs mistakes.
Shaikhani.
 
Inflammatory Bowel Disease (IBD) - Symptoms and Causes.pptx
Inflammatory Bowel Disease (IBD) - Symptoms and Causes.pptxInflammatory Bowel Disease (IBD) - Symptoms and Causes.pptx
Inflammatory Bowel Disease (IBD) - Symptoms and Causes.pptx
MediEND
 
DIET COUNSELLING.pptx
DIET COUNSELLING.pptxDIET COUNSELLING.pptx
DIET COUNSELLING.pptx
saranya suresh
 
Irritable Bowel Syndrome Part 1 - Dr Vivek Baliga
Irritable Bowel Syndrome Part 1 - Dr Vivek BaligaIrritable Bowel Syndrome Part 1 - Dr Vivek Baliga
Irritable Bowel Syndrome Part 1 - Dr Vivek Baliga
Dr Vivek Baliga
 
Ibs update 2020
Ibs update 2020Ibs update 2020
Ibs update 2020
ChernHaoChong
 
IBS Presentation - Dr. Lacy.pdf
IBS Presentation - Dr. Lacy.pdfIBS Presentation - Dr. Lacy.pdf
IBS Presentation - Dr. Lacy.pdf
Devi Seal
 
Ibs update 2020
Ibs update 2020Ibs update 2020
Ibs update 2020
ChernHaoChong
 
Linaclotide
LinaclotideLinaclotide
Linaclotide
MdSydurRahmanRimon
 
Effective treatment for irritable bowel syndrome in Mindheal Homeopathy clin...
Effective treatment for irritable bowel syndrome  in Mindheal Homeopathy clin...Effective treatment for irritable bowel syndrome  in Mindheal Homeopathy clin...
Effective treatment for irritable bowel syndrome in Mindheal Homeopathy clin...
Shewta shetty
 
A5 brochure ibs_eng
A5 brochure ibs_engA5 brochure ibs_eng
A5 brochure ibs_eng
haithamo
 
Irritable Bowel
Irritable BowelIrritable Bowel
Irritable Bowel
joeyprince
 
Therapeutic Nutrition In the Oncology Population
Therapeutic Nutrition In the Oncology Population Therapeutic Nutrition In the Oncology Population
Therapeutic Nutrition In the Oncology Population
nutritionistrepublic
 

Similar to Key messages post_launch (20)

Key messages
Key messagesKey messages
Key messages
 
A to b
A to bA to b
A to b
 
Z a to_b_shift_slides
Z a to_b_shift_slidesZ a to_b_shift_slides
Z a to_b_shift_slides
 
Git j club ibs difficult to treat21
Git j club ibs difficult to treat21Git j club ibs difficult to treat21
Git j club ibs difficult to treat21
 
IBS(Irritable Bowel Syndrome) Management Update-2021
IBS(Irritable Bowel Syndrome) Management Update-2021IBS(Irritable Bowel Syndrome) Management Update-2021
IBS(Irritable Bowel Syndrome) Management Update-2021
 
Irritable Bowel Syndrome with Constipation - Patient POV Slides - Dr. Lacy
Irritable Bowel Syndrome with Constipation - Patient POV Slides - Dr. LacyIrritable Bowel Syndrome with Constipation - Patient POV Slides - Dr. Lacy
Irritable Bowel Syndrome with Constipation - Patient POV Slides - Dr. Lacy
 
Supporting guide
Supporting guideSupporting guide
Supporting guide
 
GIT irritable bowel syndrome (IBS) for 5th year 2011
GIT irritable bowel syndrome (IBS) for 5th year 2011GIT irritable bowel syndrome (IBS) for 5th year 2011
GIT irritable bowel syndrome (IBS) for 5th year 2011
 
Git j club ibs mistakes.
Git j club ibs mistakes.Git j club ibs mistakes.
Git j club ibs mistakes.
 
Inflammatory Bowel Disease (IBD) - Symptoms and Causes.pptx
Inflammatory Bowel Disease (IBD) - Symptoms and Causes.pptxInflammatory Bowel Disease (IBD) - Symptoms and Causes.pptx
Inflammatory Bowel Disease (IBD) - Symptoms and Causes.pptx
 
DIET COUNSELLING.pptx
DIET COUNSELLING.pptxDIET COUNSELLING.pptx
DIET COUNSELLING.pptx
 
Irritable Bowel Syndrome Part 1 - Dr Vivek Baliga
Irritable Bowel Syndrome Part 1 - Dr Vivek BaligaIrritable Bowel Syndrome Part 1 - Dr Vivek Baliga
Irritable Bowel Syndrome Part 1 - Dr Vivek Baliga
 
Ibs update 2020
Ibs update 2020Ibs update 2020
Ibs update 2020
 
IBS Presentation - Dr. Lacy.pdf
IBS Presentation - Dr. Lacy.pdfIBS Presentation - Dr. Lacy.pdf
IBS Presentation - Dr. Lacy.pdf
 
Ibs update 2020
Ibs update 2020Ibs update 2020
Ibs update 2020
 
Linaclotide
LinaclotideLinaclotide
Linaclotide
 
Effective treatment for irritable bowel syndrome in Mindheal Homeopathy clin...
Effective treatment for irritable bowel syndrome  in Mindheal Homeopathy clin...Effective treatment for irritable bowel syndrome  in Mindheal Homeopathy clin...
Effective treatment for irritable bowel syndrome in Mindheal Homeopathy clin...
 
A5 brochure ibs_eng
A5 brochure ibs_engA5 brochure ibs_eng
A5 brochure ibs_eng
 
Irritable Bowel
Irritable BowelIrritable Bowel
Irritable Bowel
 
Therapeutic Nutrition In the Oncology Population
Therapeutic Nutrition In the Oncology Population Therapeutic Nutrition In the Oncology Population
Therapeutic Nutrition In the Oncology Population
 

More from haithamo

Aum profile
Aum profileAum profile
Aum profile
haithamo
 
Aum presentation
Aum presentationAum presentation
Aum presentation
haithamo
 
Aum presentation dealers meeting
Aum presentation dealers meetingAum presentation dealers meeting
Aum presentation dealers meeting
haithamo
 
Aum profile
Aum profileAum profile
Aum profile
haithamo
 
Bubble image for suv market ksa 20100805
Bubble image for suv market ksa 20100805Bubble image for suv market ksa 20100805
Bubble image for suv market ksa 20100805
haithamo
 
Feasability study
Feasability studyFeasability study
Feasability study
haithamo
 
Feasability study wout appendix
Feasability study wout appendixFeasability study wout appendix
Feasability study wout appendix
haithamo
 
Aum profile
Aum profileAum profile
Aum profile
haithamo
 
Aum presentation
Aum presentationAum presentation
Aum presentation
haithamo
 
Aum marketing plan overview 2010 in thailand
Aum marketing plan overview 2010 in thailandAum marketing plan overview 2010 in thailand
Aum marketing plan overview 2010 in thailand
haithamo
 
Alissa group profile
Alissa group profileAlissa group profile
Alissa group profile
haithamo
 
Suv
SuvSuv
July 10 sales analasis (2)
July 10 sales analasis (2)July 10 sales analasis (2)
July 10 sales analasis (2)
haithamo
 
July 10 sales analasis
July 10 sales analasisJuly 10 sales analasis
July 10 sales analasis
haithamo
 
Hyundai meeting
Hyundai meetingHyundai meeting
Hyundai meeting
haithamo
 
Geely introduction presentation
Geely introduction presentationGeely introduction presentation
Geely introduction presentation
haithamo
 
Tata meeting
Tata meetingTata meeting
Tata meeting
haithamo
 
Renault feasibility study summary for presentation
Renault feasibility study summary for presentationRenault feasibility study summary for presentation
Renault feasibility study summary for presentation
haithamo
 
Renault feasibility study summary detailed
Renault feasibility study summary detailedRenault feasibility study summary detailed
Renault feasibility study summary detailed
haithamo
 
Renault board presentation
Renault board presentationRenault board presentation
Renault board presentation
haithamo
 

More from haithamo (20)

Aum profile
Aum profileAum profile
Aum profile
 
Aum presentation
Aum presentationAum presentation
Aum presentation
 
Aum presentation dealers meeting
Aum presentation dealers meetingAum presentation dealers meeting
Aum presentation dealers meeting
 
Aum profile
Aum profileAum profile
Aum profile
 
Bubble image for suv market ksa 20100805
Bubble image for suv market ksa 20100805Bubble image for suv market ksa 20100805
Bubble image for suv market ksa 20100805
 
Feasability study
Feasability studyFeasability study
Feasability study
 
Feasability study wout appendix
Feasability study wout appendixFeasability study wout appendix
Feasability study wout appendix
 
Aum profile
Aum profileAum profile
Aum profile
 
Aum presentation
Aum presentationAum presentation
Aum presentation
 
Aum marketing plan overview 2010 in thailand
Aum marketing plan overview 2010 in thailandAum marketing plan overview 2010 in thailand
Aum marketing plan overview 2010 in thailand
 
Alissa group profile
Alissa group profileAlissa group profile
Alissa group profile
 
Suv
SuvSuv
Suv
 
July 10 sales analasis (2)
July 10 sales analasis (2)July 10 sales analasis (2)
July 10 sales analasis (2)
 
July 10 sales analasis
July 10 sales analasisJuly 10 sales analasis
July 10 sales analasis
 
Hyundai meeting
Hyundai meetingHyundai meeting
Hyundai meeting
 
Geely introduction presentation
Geely introduction presentationGeely introduction presentation
Geely introduction presentation
 
Tata meeting
Tata meetingTata meeting
Tata meeting
 
Renault feasibility study summary for presentation
Renault feasibility study summary for presentationRenault feasibility study summary for presentation
Renault feasibility study summary for presentation
 
Renault feasibility study summary detailed
Renault feasibility study summary detailedRenault feasibility study summary detailed
Renault feasibility study summary detailed
 
Renault board presentation
Renault board presentationRenault board presentation
Renault board presentation
 

Key messages post_launch

  • 1. Key Messages we are communicating The predominant symptoms of a C-IBS patient are abdominal pain, bloating and constipation. These symptoms wax and wane and affect all aspects of her life, leading to decreased quality of life. Desired outcome:  Bring to the doctor’s mind the disease area and the patient group he sees and their symptoms
  • 2. Key Messages: Disease related  The impact of IBS is high as it is a prevalent condition which takes up much of the doctors consultation time, and the cost of IBS is measured in monetary terms as well as an impact of the patients quality of life.  Desired outcome: Make IBS matter- it is not a non- disease it affects lives
  • 3. Key Message: Disease /Patient related  The impact of IBS on QOL versus other common chronic episodic ondition is often worse than the other conditions. It is therefore vital that the IBS patients are treated, so that their QOL can be improved.  Desired outcome:  You have circumstances- to create a story ..  Emphasize that IBS affects lives
  • 4. Key Message: Patient related  IBS has a serious impact on patient’s daily activities and QOL.  Desired outcome:  Make it serious- bring to the treating physician the urgency to treat patients
  • 5. Key Message: Patient related  C-IBS patients report a high incidence of abdominal pain, bloating and constipation as their predominant symptoms.  Desired outcome:  re-iterate to the doctor that the patient could use other terms for describing that she is bloated or has constipation. This again highlights the importance of the doctor asking questions and discussing her symptoms with her.
  • 6. Key Message: Product Related  Traditional therapies do not meet the need and only treat individual symptoms. The traditional therapies also exacerbate other symptoms and do not address the underlying cause of C-IBS
  • 7. Key Message: Product Related  Zelmac is the only treatment that provides multisymptom relief of C-IBS by working in 3 ways to address the underlying cause
  • 8. Key Message: Product Related  Zelmac is the only treatment available that meets all 3 criteria and provides multisymptom relief of C-IBS.
  • 9. Key Message: Product Related  Zelmac provides rapid and sustained multisymptom relief of the symptoms with C-IBS
  • 10. Key Message: Product Related  Zelmac provides rapid and sustained multisymptom relief of the symptoms with C-IBS